Donor genetic carrier screening: how to read the next steps

Understand what a carrier result can mean

For many autosomal recessive conditions, a carrier has one changed copy of a gene without having the condition. If both genetic contributors carry disease-causing changes for the same recessive condition, a child may inherit both.

MedlinePlus explains the familiar one-in-four pattern: when both contributors are carriers for an autosomal recessive disorder, each pregnancy has a 25% chance of an affected child. That is not a prediction that exactly one of four children will be affected. A genetics professional needs to interpret the particular findings.

Other inheritance patterns work differently. Some findings can also matter for a carrier's own health. Avoid treating “carrier” as either a diagnosis of illness or an assurance that a result is unimportant. Keep the actual gene, condition, and report wording together.

Review the egg and sperm reports together

ASRM's donor guidance recommends that egg and sperm sources ideally be screened for the same conditions. Different panels can cover different conditions; when panels differ, professional review helps establish whether more screening is warranted.

The relevant pair is the egg source and the sperm source. A partner who will carry a pregnancy but is not providing an egg is not the other genetic contributor for this comparison. If both eggs and sperm are donated, both donor reports belong in the review.

For example, “screened for many conditions” on one profile and “negative” on another are not enough to compare. Ask the reviewer to document what overlaps and what remains unknown.

Keep negative results in perspective

A negative result means the test did not identify the findings it was designed to detect. It does not mean all possible genetic conditions have been excluded. MedlinePlus describes the limits of genetic testing, including that a test may not provide every answer about future health.

Ask for the remaining risk to be explained in ordinary language. Useful questions are specific: Was this condition included? Does the method detect the relevant types of changes? Does the family history call for a different assessment? The answer may be that no further testing is recommended, with some uncertainty remaining.

Be cautious about comparing panel sizes as if more listed conditions automatically settle the choice. Your task is to understand the interpretation relevant to these two contributors, not to select the largest number on a profile.

Make a plan for an unresolved finding

If the review raises a concern, separate the medical decision from any reservation deadline. Find out what information is missing, whether it can reasonably be obtained, who would provide consent for additional testing, and when you can discuss the result.

• Ask the genetic counselor to name the specific reproductive concern.
• Request an explanation of the available options and their limitations.
• Clarify whether the next step changes donor selection, treatment planning, or both.
• Get the interpretation in writing so another member of your care team can follow it.

Do not assume every flagged result rules out a donor or that additional testing always resolves uncertainty. If embryo testing comes up, have the counselor explain what a proposed test would examine and what it would leave unanswered. Avoid substituting a general statement about “genetically tested embryos” for that discussion.

Keep records that remain useful later

Store the reports and counseling summary securely, with the date and a contact for follow-up. Ask how medical updates about a donor or donor-conceived relative would reach you and how you should report relevant information in return.

Before you close the file, write one short summary in your own words: the results reviewed, the unresolved limitations, and the decision you made with your professionals. Check that summary with the counselor. It is a practical way to discover a misunderstanding before it affects your next step.

Genetic screening is one part of choosing an egg donor, alongside consent, medical evaluation, and expectations about information. Cove's intended-parent path can support exploration and introductions; the interpretation belongs with your clinical and genetics team.